GALNT14 and hepatocellular carcinoma: Applying a genome-wide association method followed by prospective validation, the single-nucleotide polymorphism (SNP) rs9679162 of GALNT14 was first discovered correlating with the therapeutic outcome in patients with hepatocellular carcinoma [10].